We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Newly-Cleared Technology a Game Changer for Diagnosis of Lyme Disease

By LabMedica International staff writers
Posted on 09 Jul 2025

Lyme disease is one of the fastest-growing infectious diseases, with approximately 476,000 cases diagnosed annually in the United States. More...

The symptoms of Lyme disease, such as fever, headache, fatigue, chills, joint pain, and in some cases, a rash, make it challenging to diagnose quickly and accurately. Standard testing methods may not provide full diagnostic coverage, especially since IgM antibodies appear first and indicate a current or recent infection, while IgG antibodies, appearing weeks later, can suggest chronic or past infection. Using both IgM and IgG tests allows for full diagnostic coverage of a disease. Now, a more sensitive Lyme disease test that includes both IgM and IgG antibody detection improves the ability to detect the disease at various stages.

The iDart Lyme IgM and IgG ImmunoBlot Kits from ID-FISH Technology (Milpitas, CA, USA) feature 26 and 31 Lyme antigen bands, respectively, surpassing the antigen bands available in other Lyme immunoblot tests on the market. The inclusion of multiple antigens, including Osp A (P31) and Osp B (P34), improves the sensitivity of the test, providing a more accurate diagnosis of Lyme disease in suspected patients. The test works by identifying specific Lyme disease antigens in blood samples, which enhances diagnostic accuracy without compromising specificity.

The iDart Lyme IgM and IgG ImmunoBlot test kits were validated and have received FDA clearance, marking a significant advancement in Lyme disease diagnostics. The tests offer new criteria for interpreting results, which differ from the CDC criteria. The inclusion of bands 31 and 34 makes these the only FDA-cleared Lyme serological tests to feature these bands. ID-FISH Technology plans to start shipping these kits in late 2025, with laboratories as the primary target customers. The future goal is to expand the use of these tests to provide more reliable diagnostics for Lyme disease.

"We are delighted to have received FDA clearance for our Lyme kits," said Dr. Jyotsna Shah, PhD, Chief Scientific Officer of ID-FISH Technology. "The R&D team at ID-FISH has worked tirelessly on making sure that we deliver the most accurate tests possible for the detection of Lyme disease. We look forward to working with partners to get these tests to patients."

Related Links:
ID-FISH Technology


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.